Gonna take a shot in responding to you spinner (of course

New Post Public Reply Private Reply Replies (0) Message Board
DJknows spinner #27992
427
Gonna take a shot in responding to you spinner (of course not speaking on behalf of anybody or any entity, just my opinion from some experience with grey/pink sheet). Mr. Moscato/ Generex very specifically stated in today's PR they did not have anything to do with this 'investor/shareholder' listing of NUGX on grey/pink sheet but it must have been 'legal' as authorities (SEC/Finra or whatever entity) had to approve or ALLOW it... afterall it had to go through some authority to happen and it did happen.

Maybe Generex had to accept it once it was allowed.

Also what is written in today's CC news or Conference Call PR is as follows:

Quote:
If NuGenerex is approved for listing, the NUGX symbol will no longer be active.


To me, this means the company ( Generex ) does not condone the activity that has been going on with NUGX. I'm not sure what happens with that symbol or those shares when it is "no longer active" but I'd be weary of buying/trading it now (traders are currently making a market with it... and btw, whoever kicked it off has probably sold their shares early on when it was near the high the first few days of trading ... began 3/15/2021 @ high of $5.8/share... today closed at $1.11/pps).

And look at this, normally on OTC, a pink sheet security/stock will at least have a "Transfer Agent Verified" ... this has absolutely nothing under "Pink Current Information" at the top right:


https://www.otcmarkets.com/stock/NUGX/news

Even a "Pink no Information - Dark or Defunct" ticker with a stop sign has a "Transfer Agent Verified"... for example, take this one and there are others of course:

https://www.otcmarkets.com/stock/AMBS/overview

If an OTC had filed a 15-12G it would not have a Transfer Agent.

There could be plenty of questions asked about all of the above and more regarding NUGX.





Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading